Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxWages, Salaries and Other
Others
Ratios

Greater Cannabis Company (GCAND) Cost of Revenue (2017 - 2022)

Greater Cannabis Company (GCAND) has 6 years of Cost of Revenue data on record, last reported at $11017.0 in Q4 2022.

  • For Q4 2022, Cost of Revenue rose 112.51% year-over-year to $11017.0; the TTM value through Dec 2022 reached $52035.0, up 311.18%, while the annual FY2024 figure was $31276.0, 37.9% down from the prior year.
  • Cost of Revenue reached $11017.0 in Q4 2022 per GCAND's latest filing, down from $18054.0 in the prior quarter.
  • Across five years, Cost of Revenue topped out at $107077.0 in Q2 2019 and bottomed at -$162088.0 in Q4 2019.
  • Average Cost of Revenue over 5 years is $8251.7, with a median of $18054.0 recorded in 2022.
  • The widest YoY moves for Cost of Revenue: up 71763.76% in 2019, down 903.69% in 2019.
  • A 5-year view of Cost of Revenue shows it stood at $20168.0 in 2018, then tumbled by 903.69% to -$162088.0 in 2019, then skyrocketed by 89.03% to -$17781.0 in 2020, then crashed by 395.3% to -$88070.0 in 2021, then surged by 112.51% to $11017.0 in 2022.
  • Per Business Quant database, its latest 3 readings for Cost of Revenue were $11017.0 in Q4 2022, $18054.0 in Q3 2022, and $11784.0 in Q2 2022.